PHARMACEUTICAL PREPARATIONS COMPLEMENT MEDIATED DISEASES

Brand Owner (click to sort) Address Description
EFOCEA Omeros Corporation 201 Elliott Avenue West Seattle WA 98119 Pharmaceutical preparations for complement-mediated diseases, addiction and oncology, none of the foregoing in connection with pharmaceutical preparations for the treatment of dermatological diseases and conditions;The wording EFOCEA has no meaning in a foreign language.;
VIQUIO Omeros Corporation 201 Elliott Avenue West Seattle WA 98119 Pharmaceutical preparations for complement-mediated diseases, addiction and oncology;The wording VIQUIO has no meaning in a foreign language.;
VYLODIA Omeros Corporation 201 Elliott Avenue West Seattle WA 98119 Pharmaceutical preparations for complement-mediated diseases, addiction and oncology;The wording VYLODIA has no meaning in a foreign language.;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions while simultaneously reducing the risk of thrombotic cardiovascular events